Biotech Reading List (March 2017)

The Story Behind the First AIDS Drug
Alice Park (TIME)
​
What PCSK9 is telling us about drug development
Derek Lowe (In the Pipeline)
$AMGN $REGN $SNY $MDCO $ESPR

Turning Pfizer Discards Into Novartis Gold: The Story Of Ziarco
John LaMattina (Forbes)
$NVS $PFE

Targets: Drugability Revisited
Keith Robison (Omics! Omics! Blog)

Are right-to-try laws a last hope for dying patients — or a false hope?
Laurie McGinley (Washington Post)

A.I. vs, M.D.
Siddhartha Mukherjee (The New Yorker)